|Next: an anti-malarial drug||| Print ||
|Archives - February 2009|
In the race to cure malaria, the devastating disease that claims 1 million lives each year, every development is critical. The deadliest strain has grown increasingly resistant to chloroquine, the safest and cheapest anti-malarial drug available. The parasite that carries the virus has developed a “siphon” to purge the drug from itself. But instead of developing a new drug, a lengthy and costly process, Portland State University professor David Peyton and his research team at DesignMedix are re-engineering the original. These “reversed chloroquines” block the parasite’s siphon, killing the parasite. Some of these molecules are 10 times more effective than chloroquine alone, decreasing the required dosage significantly. Smaller doses could mean fewer side effects and lower manufacturing costs, Peyton says. The drug is expected to move to human trials in the next two to three years. Peyton sees the eradication of the disease as critical to the health of women and children, and for the health of malaria-stricken countries. “What the world needs now,” Peyton says, “is very good, very safe, very cheap anti-malarial drugs.”
|Starbucks to post nutrition info|
|Obama may not renominate Bernanke|
|Is Netflix the new HBO?|
|Processed foods looking more natural|
|Builders point to 'home within a home' housing trend|
|Apple reveals U.S. data inquiries|
|Microsoft Office finally available on iPhones|
|100 Best Green Companies to Work For in Oregon 2013|
|Design for change|
|Nurturing startup success|
|The sharing economy|
|Oregon State Treasurer Ted Wheeler balances life, work, play|
|Froelick Gallery's art dealer|
|The art whisperer|
Lane Powell is proud to announce the formal launch of their Privacy and Data Security Practice Group, which was organized to better serve their clients in this increasingly popular area — an area their attorneys have been working in for years.
From Oregon Translational Research and Development Institute: OTRADI today announced its plans to open and operate a 13,000 square-foot multi-tenant bioscience complex in the Willamette Wharf building at 4640 SW Macadam Avenue. Slated to be complete in spring 2013, the OTRADI Bioscience Incubator (OBI) will house up to six companies.
MEDIAmerica, publisher of Oregon Business and Oregon Home magazines, announces a new retail website: HalfOffOregon.com. The website offers lodging, dining, recreation and many other items at half off their regular cost.
As you probably know by now, The Vernon Company is a national leader in the promotional products industry with annual sales of over $60 million. We are a family owned business, led by the fourth generation of the Vernon family.